Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value
$33.42+0.34 (+1.03%)
Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%
Cadre EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cadre's EPS for the twelve months ending Sep 30, 2026 was $0.91, down 18.8% year over year. For fiscal 2025 it was $1.02, up 13.3% from the year before. The highest annual figure on record is $1.40 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02 | +13.3% |
| FY2024 | Dec 31, 2024 | $0.90 | -11.8% |
| FY2023 | Dec 31, 2023 | $1.02 | +537.5% |
| FY2022 | Dec 31, 2022 | $0.16 | -63.6% |
| FY2021 | Dec 31, 2021 | $0.44 | -68.6% |
| FY2020 | Dec 31, 2020 | $1.40 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.37 | +37.0% |
| Q2 FY2026 | Jun 30, 2026 | $0.26 | -13.3% |
| Q1 FY2026 | Mar 31, 2026 | $0.05 | -78.3% |
| Q4 FY2025 | Dec 31, 2025 | $0.23 | -28.1% |
| Q3 FY2025 | Sep 30, 2025 | $0.27 | +200.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.30 | -3.2% |
| Q1 FY2025 | Mar 31, 2025 | $0.23 | +27.8% |
| Q4 FY2024 | Dec 31, 2024 | $0.32 | +28.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.09 | -69.0% |
| Q2 FY2024 | Jun 30, 2024 | $0.31 | +6.9% |
| Q1 FY2024 | Mar 31, 2024 | $0.18 | -5.3% |
| Q4 FY2023 | Dec 31, 2023 | $0.25 | +38.9% |
| Q3 FY2023 | Sep 30, 2023 | $0.29 | +123.1% |
| Q2 FY2023 | Jun 30, 2023 | $0.29 | +141.7% |
| Q1 FY2023 | Mar 31, 2023 | $0.19 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.18 | +38.5% |
| Q3 FY2022 | Sep 30, 2022 | $0.13 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.12 | -52.0% |
| Q1 FY2022 | Mar 31, 2022 | -$0.30 | -220.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.13 | -77.2% |
| Q3 FY2021 | Sep 30, 2021 | -$0.19 | -182.6% |
| Q2 FY2021 | Jun 30, 2021 | $0.25 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.25 | – |
| Q4 FY2020 | Dec 31, 2020 | $0.57 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.23 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?